Advanced Forum ViewPharmaceutical Jobs Healthcare Social Network

Forum Topic News

Search in the sub-forums

News

503 conversations, 505 comments, 1,255,323 views

- Latest Comments
  
  Comments/Views
  
  Conversations
- by PHARMeMED
  
  July 15, 2020
  
  1 / 2,277
  
  FDA committee backs GSK's multiple myeloma drug
  
  Posted on July 15, 2020 by PHARMeMED
  
  by PHARMeMED
  
  July 15, 2020
  
  1 / 2,318
  
  Moderna’s COVID-19 vaccine produces immune response in early trial
  
  Posted on July 15, 2020 by PHARMeMED
  
  by PHARMeMED
  
  July 14, 2020
  
  1 / 2,318
  
  Biogen, Eisai take Alzheimer’s candidate BAN2401 into phase 3
  
  Posted on July 14, 2020 by PHARMeMED
  
  by PHARMeMED
  
  July 13, 2020
  
  1 / 2,502
  
  Experimental motor neurone disease therapy shows early promise
  
  Posted on July 13, 2020 by PHARMeMED
  
  by PHARMeMED
  
  July 13, 2020
  
  1 / 2,372
  
  Clinigen's ALS therapy bags US orphan status
  
  Posted on July 13, 2020 by PHARMeMED
  
  by PHARMeMED
  
  July 2, 2020
  
  1 / 2,478
  
  Affinity discovers potent SARS-CoV-2 antibodies
  
  Posted on July 2, 2020 by PHARMeMED
  
  by PHARMeMED
  
  June 30, 2020
  
  1 / 2,693
  
  Carmine Therapeutics and Takeda Collaborate to Discover and Develop Rare Disease Gene Therapies Using Novel Red Blood Cell Extra...
  
  Posted on June 30, 2020 by PHARMeMED
  
  by PHARMeMED
  
  June 29, 2020
  
  1 / 2,501
  
  Vertex’s triple CF therapy scores recommendation from CHMP
  
  Posted on June 29, 2020 by PHARMeMED
  
  by PHARMeMED
  
  June 23, 2020
  
  1 / 2,537
  
  Gilead will test inhaled remdesivir in earlier-stage COVID-19
  
  Posted on June 23, 2020 by PHARMeMED
  
  by PHARMeMED
  
  June 23, 2020
  
  1 / 2,376
  
  Sanofi pays $300m upfront to expand deal with Translate Bio
  
  Posted on June 23, 2020 by PHARMeMED
  
  by PHARMeMED
  
  June 19, 2020
  
  1 / 2,400
  
  EU filing for CPP's familial adenomatous polyposis drug
  
  Posted on June 19, 2020 by PHARMeMED
  
  by PHARMeMED
  
  June 19, 2020
  
  1 / 2,353
  
  Mylan Wins District Court Decision Against Biogen's Tecfidera® Patent
  
  Posted on June 19, 2020 by PHARMeMED
  
  by PHARMeMED
  
  June 17, 2020
  
  1 / 2,429
  
  Armata Pharmaceuticals Announces $15 Million Award from the U.S. Department of Defense (DoD) for Development of Bacteriophage Th...
  
  Posted on June 17, 2020 by PHARMeMED
  
  by PHARMeMED
  
  June 16, 2020
  
  1 / 2,620
  
  Celltrion's infliximab biosimilar to be tested for COVID-19
  
  Posted on June 16, 2020 by PHARMeMED
  
  by PHARMeMED
  
  June 15, 2020
  
  1 / 2,420
  
  AZ signs deal with Europe's IVA for coronavirus vaccine supply
  
  Posted on June 15, 2020 by PHARMeMED
  
  by PHARMeMED
  
  February 4, 2020
  
  1 / 2,730
  
  'Green' Medical Propellant Receives FDA Approval to Proceed to Clinical Trials
  
  Posted on February 4, 2020 by PHARMeMED
  
  by PHARMeMED
  
  April 8, 2019
  
  1 / 2,997
  
  Researchers Report SX-682 Could Enhance Multiple Forms of T Cell-Based Immunotherapies in Solid Tumors
  
  Posted on April 8, 2019 by PHARMeMED
  
  by PHARMeMED
  
  April 5, 2019
  
  1 / 3,524
  
  Indivior's RECOVER™ Study Finds Three-quarters of Patients with Moderate to Severe Opioid Use Disorder Who Received 12 monthly I...
  
  Posted on April 5, 2019 by PHARMeMED
  
  by PHARMeMED
  
  March 29, 2019
  
  1 / 2,976
  
  Luye Pharma's Rykindo® Expected to Be the First Chinese Innovative Drug to Receive U.S. FDA Approval
  
  Posted on March 29, 2019 by PHARMeMED
  
  by PHARMeMED
  
  March 26, 2019
  
  1 / 2,898
  
  Johnson & Johnson Vision's Investigational Antihistamine-Releasing Contact Lens Demonstrates Positive Phase 3 Results
  
  Posted on March 26, 2019 by PHARMeMED
  
  by PHARMeMED
  
  March 15, 2019
  
  1 / 2,951
  
  Interim Analysis Showed Treatment with OPSUMIT® (macitentan) Associated with Significant Improvement in Right Ventricular (RV) F...
  
  Posted on March 15, 2019 by PHARMeMED
  
  by PHARMeMED
  
  March 12, 2019
  
  1 / 2,991
  
  AARP Launches 'Stop Rx Greed' Campaign Targeting High Prescription Drug Prices
  
  Posted on March 12, 2019 by PHARMeMED
  
  by PHARMeMED
  
  March 5, 2019
  
  1 / 2,991
  
  AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes
  
  Posted on March 5, 2019 by PHARMeMED
  
  by PHARMeMED
  
  February 22, 2019
  
  1 / 3,059
  
  Enzychem Lifesciences Completes Stage 1 Patient Enrollment in Phase 2 CRIOM Study
  
  Posted on February 22, 2019 by PHARMeMED
  
  by PHARMeMED
  
  February 21, 2019
  
  1 / 3,053
  
  Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patien...
  
  Posted on February 21, 2019 by PHARMeMED
  Mark All as Read
  
  Quick navigation
  « Previous
  
  3
  
  4
  
  5
  
  6
  
  7
  
  8
  
  9
  
  10
  
  11
  
  12
  
  Next »

Sign In or Join

News